Lipocine (LPCN) Income Annual - Discounting Cash Flows
Lipocine Inc.
LPCN (NASDAQ)

* (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
Report Filing 2025-03-13 2024-03-07 2023-03-10 2022-03-09 2021-03-11 2020-03-13 2019-03-06 2018-03-12 2017-03-06 2016-03-10 2015-03-11 2014-03-31 2013-02-26 2012-04-30
Revenue
11.2 -2.85 0.50 16.1 0.00 0.16 0.43 0.00 0.00 0.00 0.00 0.00 7.71 0.00
Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.28 0.00
Gross Profit
11.2 -2.85 0.50 16.1 0.00 0.16 0.43 0.00 0.00 0.00 0.00 0.00 5.43 0.00
Operating Expenses
12.4 15.1 12.6 13.0 18.0 13.1 11.8 21.2 18.5 18.4 20.5 8.76 1.55 0.01
Research & Development
7.35 10.2 8.56 7.67 9.75 7.47 6.46 11.0 8.08 12.6 15.5 5.59 3.04 0.00
Selling, General and Administrative
5.00 4.90 4.06 5.33 8.25 5.60 5.29 10.2 10.4 5.80 5.00 3.64 1.55 0.00
Other Operating Expenses
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.47 -3.04 0.00
Operating Income
-1.16 -17.9 -12.1 3.15 -18.0 -12.9 -11.3 -21.2 -18.5 -18.4 -20.5 -8.76 3.88 -0.01
Net Non-Operating Interest
1.15 1.37 0.52 -0.07 0.31 0.34 0.00 0.00 0.00 0.17 0.11 0.04 0.01 0.00
Interest Income
1.15 1.37 0.55 0.14 0.31 0.34 0.00 0.00 0.00 0.17 0.11 0.04 0.01 0.00
Interest Expense
0.00 0.00 0.03 0.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity & Other Income/(Expense)
0.02 0.21 0.84 -3.71 -3.28 -0.45 -0.33 0.24 -0.51 0.00 0.00 -1.93 0.00 0.00
Income Before Tax
0.01 -16.4 -10.8 -0.63 -21.0 -13.0 -11.7 -21.0 -19.0 -18.2 -20.4 -10.6 3.89 -0.01
Income Tax Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.00 0.00
Income Attributable to Non-Controlling Interest
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.11 0.09 0.00
Net Income
0.01 -16.4 -10.8 -0.63 -21.0 -13.0 -11.7 -21.0 -19.0 -18.2 -20.4 -10.6 3.80 -0.01
Depreciation and Amortization
0.04 0.03 0.01 0.00 0.00 0.02 0.02 0.03 0.03 0.03 0.01 0.02 0.04 0.00
EBITDA
-1.11 -17.9 -12.1 3.15 -18.0 -12.9 -11.3 -21.2 -18.4 -18.4 -20.5 -8.74 3.92 -0.01
Earnings Per Share (EPS)
0.002 -3.140 -2.150 -0.190 -6.460 -8.540 -9.350 -17.79 -17.66 -18.79 -27.13 -24.45 14.50 -2.930
Diluted Earnings Per Share
0.002 -3.140 -2.050 -0.120 -6.400 -8.540 -9.280 -17.85 -17.68 -18.87 -27.20 -24.48 14.45 -2.930
Weighted Average Shares Outstanding
5.34 5.27 4.99 3.30 3.25 1.52 1.25 1.18 1.07 0.96 0.75 0.43 0.26 0.00
Diluted Weighted Average Shares Outstanding
5.42 5.27 5.26 5.15 3.28 1.52 1.26 1.18 1.07 0.97 0.75 0.43 0.26 0.00
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us